Trial Profile
Azithromycin therapy for bronchiolitis obliterans syndrome after allogenic bone marrow transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2007
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Bronchiolitis obliterans
- Focus Therapeutic Use
- 14 Dec 2007 New trial record.